Outcomes in Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC)

[1] Shaib W(2016)Appendiceal neuroendocrine, goblet and signet-ring cell tumors: a spectrum of diseases with different patterns of presentation and outcome Cancer Res Treat Official J Korean Cancer Assoc 48 596-604

[2] Krishna K(2017)Neuroendocrine, goblet cell and mixed adeno-neuroendocrine tumours of the appendix: updates, clinical applications and the future Exp Rev Gastroent Hepatol 11 237-247

[3] Kim S(2018)Goblet cell carcinomas of the appendix: rare but aggressive neoplasms with challenging management Endocr Connect 7 268-277

[4] Clift AK(2017)Appendiceal goblet cell carcinoid: common errors in staging and clinical interpretation with a proposal for an improved terminology Hum Pathol 65 187-193

[5] Frilling A(2010)Combined classical carcinoid and goblet cell carcinoid tumor: a new morphologic variant of carcinoid tumor of the appendix Am J Surg Pathol 34 1163-1167

[6] Clift AK(1990)Goblet cell carcinoids and related tumors of the vermiform appendix Am J Clin Pathol 94 27-35

[7] Kornasiewicz O(2015)Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis Arch Pathol Lab Med. 139 782-790

[8] Drymousis P(2006)Surgical and chemotherapy treatment outcomes of goblet cell carcinoid: a tertiary cancer center experience Ann Surg Oncol. 13 370-376

[9] Wen KW(2018)Effects of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of goblet cell carcinoma: a prospective cohort study Ann Surg Oncol. 25 422-430

[10] Hale G(2012)Neoplasms of the appendix: current treatment guidelines Hematol Oncol Clin North Am 26 1261-1290

[1] Shaib W(2016)Appendiceal neuroendocrine, goblet and signet-ring cell tumors: a spectrum of diseases with different patterns of presentation and outcome Cancer Res Treat Official J Korean Cancer Assoc 48 596-604

[2] Krishna K(2017)Neuroendocrine, goblet cell and mixed adeno-neuroendocrine tumours of the appendix: updates, clinical applications and the future Exp Rev Gastroent Hepatol 11 237-247

[3] Kim S(2018)Goblet cell carcinomas of the appendix: rare but aggressive neoplasms with challenging management Endocr Connect 7 268-277

[4] Clift AK(2017)Appendiceal goblet cell carcinoid: common errors in staging and clinical interpretation with a proposal for an improved terminology Hum Pathol 65 187-193

[5] Frilling A(2010)Combined classical carcinoid and goblet cell carcinoid tumor: a new morphologic variant of carcinoid tumor of the appendix Am J Surg Pathol 34 1163-1167

[6] Clift AK(1990)Goblet cell carcinoids and related tumors of the vermiform appendix Am J Clin Pathol 94 27-35

[7] Kornasiewicz O(2015)Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis Arch Pathol Lab Med. 139 782-790

[8] Drymousis P(2006)Surgical and chemotherapy treatment outcomes of goblet cell carcinoid: a tertiary cancer center experience Ann Surg Oncol. 13 370-376

[9] Wen KW(2018)Effects of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of goblet cell carcinoma: a prospective cohort study Ann Surg Oncol. 25 422-430

[10] Hale G(2012)Neoplasms of the appendix: current treatment guidelines Hematol Oncol Clin North Am 26 1261-1290